50242-0918 TECENTRIQ - CanMED: NDC

Product NDC:

50242-0918

Brand Name:

TECENTRIQ

Generic Name:

Atezolizumab

Dosage Form Name:

INJECTION, SOLUTION

Administration Route:

Intravenous

Substances:

Name: ATEZOLIZUMAB

Strength: 840.0

Unit: mg/14mL

Packages:

Code: 50242-0918-01

Description: 1 VIAL, SINGLE-USE in 1 CARTON (50242-918-01) / 14 mL in 1 VIAL, SINGLE-USE

Effective Date: March 8, 2019

Discontinued:

Code: 50242-0918-86

Description: 1 VIAL, SINGLE-USE in 1 CARTON (50242-918-86) > 14 mL in 1 VIAL, SINGLE-USE

Effective Date: March 8, 2019

Discontinued: March 18, 2019

SEER*Rx Category:

Immunotherapy

Major Class:

Checkpoint Inhibitor

Minor Class:

PD-L1

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox